Source: Journal of Neuroimmunology. Unidade: FMRP
Subjects: ESCLEROSE MÚLTIPLA, CITOCINAS (IMUNOLOGIA;BIOSSÍNTESE), ENCEFALOMIELITE ANIMAL (EXPERIMENTAÇÃO), VACINAS (FARMACOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZORZELLA-PEZAVENTO, Sofia Fernanda et al. Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS. Journal of Neuroimmunology, v. 268, n. 1-2, p. 35-42, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jneuroim.2013.12.015. Acesso em: 17 out. 2024.APA
Zorzella-Pezavento, S. F., Chiuso-Minicucci, F., França, T. G. D., Ishikawa, L. L. W., Rosa, L. C. da, Colavite, P. M., et al. (2014). Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS. Journal of Neuroimmunology, 268( 1-2), 35-42. doi:10.1016/j.jneuroim.2013.12.015NLM
Zorzella-Pezavento SF, Chiuso-Minicucci F, França TGD, Ishikawa LLW, Rosa LC da, Colavite PM, Marques C, Ikoma MRV, Silva CL, Sartori A. Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS [Internet]. Journal of Neuroimmunology. 2014 ; 268( 1-2): 35-42.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.jneuroim.2013.12.015Vancouver
Zorzella-Pezavento SF, Chiuso-Minicucci F, França TGD, Ishikawa LLW, Rosa LC da, Colavite PM, Marques C, Ikoma MRV, Silva CL, Sartori A. Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS [Internet]. Journal of Neuroimmunology. 2014 ; 268( 1-2): 35-42.[citado 2024 out. 17 ] Available from: https://doi.org/10.1016/j.jneuroim.2013.12.015